News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

November 22, 2023

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

September 26, 2023

Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device

August 18, 2023

Satio Partners with BARDA DRIVe to Develop a Novel Patch-based Ebolavirus Diagnostic

Sapphiros Appoints Industry Veteran Andrew Garfield to Lead Technology Transfer to Manufacturing

GrapheneDx, General Graphene Corp and Sapphiros Enter Into Strategic Partnership to Industrialize Graphene-Based Biosensors to Revolutionize Point of Care and Consumer Diagnostics

Sapphiros Awarded $11M from NIH RADx® Tech to Develop a Next-generation Molecular OTC Test